Filed Under:

Novartis Ruling Reverberates Past India's Borders

Play associated audio
India's Supreme Court says drug maker Novartis can't hold onto its patent for the pricey cancer drug Gleevec simply by tweaking its chemical formula. That means generic drug makers can keep making a form of the drug at a tenth of Novartis's price. Consumer advocates call it a major advance for access to generic drugs. The drug industry says it will chill companies' willingness to produce innovative products.
WAMU 88.5

What The African American History Museum Means to D.C.'s Black Community

This weekend, D.C. celebrated the opening of the National Museum of African American History and Culture. Kojo chats with the civil rights leader and longtime city council member who chaired the D.C. host committee.

NPR

Sunday Sports: Baseball Season Stats

As the baseball season enters the homestretch, Mike Pesca, host of The Gist podcast shares obscure baseball stats and somewhat dubious accomplishments with NPR's Rachel Martin.
NPR

What Does It Take To Win A Debate? A Meaningful Exchange Can Make A Difference

The first presidential debate is Monday, both candidates hoping to do well. But what does it mean to "win" a debate? American University history professor Allan Lichtman explains.
WAMU 88.5

Putting The Patient At The Center Of Local Healthcare

From "concierge" services to iPads connecting new parents with their babies in the nursery, Kojo explores some of the patient-centered ideas coming from healthcare innovation labs at local hospitals.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.